ATE171447T1 - Benzimidazole derivate - Google Patents
Benzimidazole derivateInfo
- Publication number
- ATE171447T1 ATE171447T1 AT94909233T AT94909233T ATE171447T1 AT E171447 T1 ATE171447 T1 AT E171447T1 AT 94909233 T AT94909233 T AT 94909233T AT 94909233 T AT94909233 T AT 94909233T AT E171447 T1 ATE171447 T1 AT E171447T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- date sep
- benzimidazole derivatives
- sec
- pub
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939305628A GB9305628D0 (en) | 1993-03-18 | 1993-03-18 | Therapeutic agents |
| GB939316258A GB9316258D0 (en) | 1993-08-05 | 1993-08-05 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE171447T1 true ATE171447T1 (de) | 1998-10-15 |
Family
ID=26302612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94909233T ATE171447T1 (de) | 1993-03-18 | 1994-03-16 | Benzimidazole derivate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5714498A (de) |
| EP (1) | EP0689535B1 (de) |
| JP (1) | JPH08508030A (de) |
| AT (1) | ATE171447T1 (de) |
| AU (1) | AU679045B2 (de) |
| CA (1) | CA2156836A1 (de) |
| DE (1) | DE69413523T2 (de) |
| ES (1) | ES2121193T3 (de) |
| WO (1) | WO1994021615A1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604036D0 (en) * | 1996-02-26 | 1996-04-24 | Merck Sharp & Dohme | Therapeutic agents |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| GB9605065D0 (en) * | 1996-03-11 | 1996-05-08 | Merck Sharp & Dohme | Therapeutic agents |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| DK1065205T3 (da) * | 1998-03-18 | 2003-06-23 | Taisho Pharmaceutical Co Ltd | Heteroaromatiske derivater |
| AU747508B2 (en) | 1998-03-19 | 2002-05-16 | Nihon Nohyaku Co., Ltd. | Arylpiperidine derivatives and use thereof |
| US6130235A (en) * | 1998-05-22 | 2000-10-10 | Scios Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6448257B1 (en) | 1998-05-22 | 2002-09-10 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6867209B1 (en) | 1998-05-22 | 2005-03-15 | Scios, Inc. | Indole-type derivatives as inhibitors of p38 kinase |
| US6589954B1 (en) * | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6340685B1 (en) | 1998-05-22 | 2002-01-22 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| IL146309A (en) * | 1999-05-21 | 2008-03-20 | Scios Inc | Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38 |
| US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
| US6489477B1 (en) | 1999-10-29 | 2002-12-03 | Merck & Co., Inc. | 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists |
| US6369076B1 (en) * | 1999-10-29 | 2002-04-09 | Merck & Co. Inc. | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists |
| US6432976B1 (en) * | 1999-10-29 | 2002-08-13 | Merck & Co., Inc. | 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists |
| US6495561B2 (en) | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| US6476041B1 (en) * | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| US6291499B1 (en) | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| US6380205B1 (en) | 1999-10-29 | 2002-04-30 | Merck & Co., Inc. | 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| EP1235572A2 (de) * | 1999-10-29 | 2002-09-04 | MERCK SHARP & DOHME LTD. | Schmerzbehandlungsmethode mit benzimidazol nmda/nr2b antagonisten |
| US7842068B2 (en) * | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
| US6806275B2 (en) | 2000-09-13 | 2004-10-19 | Nihon Nohyaku Co., Ltd. | Arylpiperidine derivatives and use thereof |
| WO2002068409A1 (en) | 2001-02-23 | 2002-09-06 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
| US7022728B2 (en) * | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
| US7259157B2 (en) | 2001-04-03 | 2007-08-21 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
| GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
| GB0508318D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| GB0508314D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| GB0508319D0 (en) | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| CN106986862A (zh) | 2010-12-22 | 2017-07-28 | Abbvie 公司 | 丙型肝炎抑制剂及其用途 |
| CN110325530B (zh) | 2016-12-16 | 2022-01-11 | 辉瑞大药厂 | Glp-1受体激动剂及其用途 |
| US10934279B2 (en) | 2018-06-13 | 2021-03-02 | Pfizer Inc. | GLP-1 receptor agonists and uses thereof |
| FI4408840T3 (fi) | 2021-09-27 | 2025-11-04 | Terns Pharmaceuticals Inc | Bentsimidatsolikarboksyylihappoja glp-1r-agonisteina |
| IL312364A (en) | 2021-10-25 | 2024-06-01 | Luehr Gary W | Compounds as GLP-1R agonists |
| US12410163B2 (en) | 2022-02-23 | 2025-09-09 | Terns Pharmaceuticals, Inc. | Compounds as GLP-IR agonists |
| WO2024211898A1 (en) | 2023-04-07 | 2024-10-10 | Terns Pharmaceuticals, Inc. | Combination comprising a thrbeta agonist anda glp-1r agonist for use in treating a liver disorder or a cardiometabolic disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1417745A (en) * | 1973-07-07 | 1975-12-17 | Beecham Group Ltd | Chromene compounds |
| EP0034249B1 (de) * | 1980-02-08 | 1984-10-24 | Gruppo Lepetit S.P.A. | Naphthimidazol- und Naphthoxazol-Derivate, ihre Herstellung und ihre Verwendung in Pharmazeutika |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| JP2643168B2 (ja) * | 1987-08-24 | 1997-08-20 | エーザイ株式会社 | 不整脈治療・予防剤 |
| CA2022451C (en) * | 1989-08-03 | 2001-01-23 | Albert Anthony Carr | Anti-psychotic piperidynl benzimidazole compounds |
| US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
-
1994
- 1994-03-16 JP JP6520781A patent/JPH08508030A/ja active Pending
- 1994-03-16 AT AT94909233T patent/ATE171447T1/de not_active IP Right Cessation
- 1994-03-16 ES ES94909233T patent/ES2121193T3/es not_active Expired - Lifetime
- 1994-03-16 EP EP94909233A patent/EP0689535B1/de not_active Expired - Lifetime
- 1994-03-16 AU AU62156/94A patent/AU679045B2/en not_active Ceased
- 1994-03-16 US US08/530,099 patent/US5714498A/en not_active Expired - Fee Related
- 1994-03-16 CA CA002156836A patent/CA2156836A1/en not_active Abandoned
- 1994-03-16 WO PCT/GB1994/000528 patent/WO1994021615A1/en not_active Ceased
- 1994-03-16 DE DE69413523T patent/DE69413523T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08508030A (ja) | 1996-08-27 |
| AU679045B2 (en) | 1997-06-19 |
| CA2156836A1 (en) | 1994-09-29 |
| DE69413523D1 (de) | 1998-10-29 |
| US5714498A (en) | 1998-02-03 |
| DE69413523T2 (de) | 1999-05-12 |
| EP0689535A1 (de) | 1996-01-03 |
| EP0689535B1 (de) | 1998-09-23 |
| AU6215694A (en) | 1994-10-11 |
| WO1994021615A1 (en) | 1994-09-29 |
| ES2121193T3 (es) | 1998-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69413523D1 (de) | Benzimidazole derivate | |
| ATE144773T1 (de) | Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne | |
| DK0840732T3 (da) | Substituerede benzolactamforbindelser som substans P-antagonister | |
| DE69823344D1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
| ID29552A (id) | Senyawa-senyawa triazola dan penggunaannya | |
| BR9806752A (pt) | Ftalazinonas. | |
| DE69420394D1 (de) | Pyrrolopyridinderivate als dopaminrezeptor liganden | |
| DE69935670D1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
| DE69633943D1 (de) | Morphine derivate mit analgetischen eigenschaften | |
| ATE174591T1 (de) | Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor- subtyps | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| TR199701536T1 (xx) | Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�. | |
| MX9604765A (es) | Derivados de 5-heterociclico 1,5-benzodiazepinas que modulan la cck o gastrina. | |
| DE69521037D1 (de) | Chinazolinylamino derivate mit alfa-antagonist wirkung | |
| TR199902094T2 (xx) | 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri. | |
| ATE160773T1 (de) | Kondensierte tricyclische heteroaromatische verbindungen als dopamin-rezeptor-subtyp-liganden | |
| DE69412073D1 (de) | Xanthinderivate als adenosin-a1 rezeptor antagonisten | |
| DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| ES2088661T3 (es) | Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos. | |
| NO952427D0 (no) | Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5 | |
| BR0014145A (pt) | Compostos de benzimidazol substituìdo por alcóxi, preparações farmacêuticas contendo o mesmo, e métodos de uso do mesmo | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| ATE255112T1 (de) | 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |